Tesamorelin: why the labeled indication matters

Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.

A branded tesamorelin medicine is FDA approved for a specific use involving excess abdominal fat in adults with HIV and lipodystrophy. That approval does not establish a general healthy-aging, weight-management, or performance use. Compounded or otherwise unapproved versions are not FDA-approved products.